Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Chanakya Kundu

Professor

KIIT University

No Info

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (5)

Bijesh Kumar Biswal

Associate Professor

National Institute of Technology Rourkela

View details

Jasaswini Tripathy

Associate Professor

KIIT University

View details

Chandrabose Karthikeyan

Associate Staff Scientist

University of Arkansas for Medical Sciences

UNITED STATES

View details

Sabita Patel

Associate Professor

National Institute of Technology Rourkela

View details

Bipasa Kar

Scientist

University of Würzburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chanakya Kundu

Research Interests

Make your next move.

Explore related searches

Articles (20)

Anticancer Active Cyclometalated Iridium(III) Complexes Bearing Substituted 1,2,4-Triazine: Biomolecular Interactions and Gene Expression Studies in Drosophila melanogaster

Amphiphilic Poly(ethylene glycol)-Cholesterol Conjugate: Stable Micellar Formulation for Efficient Loading and Effective Intracellular Delivery of Curcumin

Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects

TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions

Identification of potential inhibitor against CTX-M-3 and CTX-M-15 proteins: an in silico and in vitro study

In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation

Computational and <i>in vitro</i> screening validates the repositioning potential of Coxibs as anti-fibrotic agents

Generation of Cancer Stem Cells by Co-Culture Methods

Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment

Improving the therapeutic window of anticancer agents by β-cyclodextrin encapsulation: Experimental and theoretical insights

Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells

Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21

Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents

The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth

The role of viruses in cancer progression versus cancer treatment: A dual paradigm

Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A

Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway

Collaborators (5)

Bijesh Kumar Biswal

Jasaswini Tripathy

Chandrabose Karthikeyan

Sabita Patel

Bipasa Kar

Make your next move.